HECT and RING finger families of E3 ubiquitin ligases at a glance

Journal of Cell Science

Volumn 125, Issue 3, 2012, Pages 531-537

  Metzger, Meredith B ^a   Hristova, Ventzislava A ^a   Weissman, Allan M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN MDM2; PROTEIN P53; RING FINGER PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELLULAR DISTRIBUTION; DNA REPAIR; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN INTERACTION; RING FINGER MOTIF; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MDM2; RING FINGER DOMAINS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

ANNA; HELLE;

EID: 84858142724     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.091777     Document Type: Article

References (145)

1. Acconcia, F., Sigismund, S. and Polo, S. (2009). Ubiquitin in trafficking: the network at work. Exp. Cell Res. 315, 1610-1618.
2. Amano, T., Yamasaki, S., Yagishita, N., Tsuchimochi, K., Shin, H., Kawahara, K., Aratani, S., Fujita, H., Zhang, L., Ikeda, R. et al. (2003). Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev. 17, 2436-2449.
3. Aravind, L. and Koonin, E. V. (2000). The U box is a modified RING finger-a common domain in ubiquitination. Curr. Biol. 10, R132-R134.
4. Ballar, P. and Fang, S. (2008). Regulation of ER-associated degradation via p97/VCP-interacting motif. Biochem. Soc. Trans. 36, 818-822.
5. Ballar, P., Ors, A. U., Yang, H. and Fang, S. (2010). Differential regulation of CFTRDeltaF508 degradation by ubiquitin ligases gp78 and Hrd1. Int. J. Biochem. Cell Biol. 42, 167-173.
6. Ballinger, C. A., Connell, P., Wu, Y., Hu, Z., Thompson, L. J., Yin, L. Y. and Patterson, C. (1999). Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell. Biol. 19, 4535-4545.
7. Bazirgan, O. A. and Hampton, R. Y. (2008). Cue1p is an activator of Ubc7p E2 activity in vitro and in vivo. J. Biol. Chem. 283, 12797-12810.
8. Behrends, C. and Harper, J. W. (2011). Constructing and decoding unconventional ubiquitin chains. Nat. Struct. Mol. Biol. 18, 520-528.
9. Bengtson, M. H. and Joazeiro, C. A. (2010). Role of a ribosome-associated E3 ubiquitin ligase in protein quality control. Nature 467, 470-473.
10. Benita, Y., Kikuchi, H., Smith, A. D., Zhang, M. Q., Chung, D. C. and Xavier, R. J. (2009). An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res. 37, 4587-4602.
11. Bernasconi, R. and Molinari, M. (2011). ERAD and ERAD tuning: disposal of cargo and of ERAD regulators from the mammalian ER. Curr. Opin. Cell Biol. 23, 176-183.
12. Brzovic, P. S., Rajagopal, P., Hoyt, D. W., King, M. C. and Klevit, R. E. (2001). Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8, 833-837.
13. Buchwald, G., van der Stoop, P., Weichenrieder, O., Perrakis, A., van Lohuizen, M. and Sixma, T. K. (2006). Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b. EMBO J. 25, 2465-2474.
14. Cadwell, K. and Coscoy, L. (2005). Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309, 127-130.
15. Carvalho, A. F., Pinto, M. P., Grou, C. P., Alencastre, I. S., Fransen, M., Sa-Miranda, C. and Azevedo, J. E. (2007). Ubiquitination of mammalian Pex5p, the peroxisomal import receptor. J. Biol. Chem. 282, 31267-31272.
16. Chen, B., Mariano, J., Tsai, Y. C., Chan, A. H., Cohen, M. and Weissman, A. M. (2006). The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. Proc. Natl. Acad. Sci. USA 103, 341-346.
17. Cheung, H. H., Plenchette, S., Kern, C. J., Mahoney, D. J. and Korneluk, R. G. (2008). The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways. Mol. Biol. Cell 19, 2729-2740.
18. Choi, Y. E., Butterworth, M., Malladi, S., Duckett, C. S., Cohen, G. M. and Bratton, S. B. (2009). The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing. J. Biol. Chem. 284, 12772-12782.
19. Ciechanover, A. and Ben-Saadon, R. (2004). N-terminal ubiquitination: more protein substrates join in. Trends Cell. Biol. 14, 103-106.
20. Clague, M. J. and Urbe, S. (2010). Ubiquitin: same molecule, different degradation pathways. Cell 143, 682-685.
21. Connell, P., Ballinger, C. A., Jiang, J., Wu, Y., Thompson, L. J., Hohfeld, J. and Patterson, C. (2001). The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell Biol. 3, 93-96.
22. Cyr, D. M., Hohfeld, J. and Patterson, C. (2002). Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem. Sci. 27, 368-375.
23. Das, R., Mariano, J., Tsai, Y. C., Kalathur, R. C., Kostova, Z., Li, J., Tarasov, S. G., McFeeters, R. L., Altieri, A. S., Ji, X. et al. (2009). Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol. Cell 34, 674-685.
24. Deshaies, R. J. and Joazeiro, C. A. (2009). RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434.
25. Diao, J., Zhang, Y., Huibregtse, J. M., Zhou, D. and Chen, J. (2008). Crystal structure of SopA, a Salmonella effector protein mimicking a eukaryotic ubiquitin ligase. Nat. Struct. Mol. Biol. 15, 65-70.
26. Du, C., Fang, M., Li, Y., Li, L. and Wang, X. (2000). Smac, a mitochondrial protein that promotes cytochrome cdependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42.
27. Eckelman, B. P., Salvesen, G. S. and Scott, F. L. (2006). Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7, 988-994.
28. Eisele, F. and Wolf, D. H. (2008). Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1. FEBS Lett. 582, 4143-4146.
29. Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H. and Weissman, A. M. (2000). Mdm2 is a RING fingerdependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945-8951.
30. Fang, S., Ferrone, M., Yang, C., Jensen, J. P., Tiwari, S. and Weissman, A. M. (2001). The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 98, 14422-14427.
31. Frescas, D. and Pagano, M. (2008). Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438-449.
32. Gagne, J. M., Downes, B. P., Shiu, S. H., Durski, A. M. and Vierstra, R. D. (2002). The F-box subunit of the SCF E3 complex is encoded by a diverse superfamily of genes in Arabidopsis. Proc. Natl. Acad. Sci. USA 99, 11519-11524.
33. Gardner, R. G., Nelson, Z. W. and Gottschling, D. E. (2005). Degradation-mediated protein quality control in the nucleus. Cell 120, 803-815.
34. Garrison, J. B., Correa, R. G., Gerlic, M., Yip, K. W., Krieg, A., Tamble, C. M., Shi, R., Welsh, K., Duggineni, S., Huang, Z. et al. (2011). ARTS and Siah collaborate in a pathway for XIAP degradation. Mol. Cell 41, 107-116.
35. Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
36. Hatakeyama, S., Yada, M., Matsumoto, M., Ishida, N. and Nakayama, K. I. (2001). U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 276, 33111-33120.
37. Hatakeyama, S., Matsumoto, M., Kamura, T., Murayama, M., Chui, D. H., Planel, E., Takahashi, R., Nakayama, K. I. and Takashima, A. (2004). U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on fourrepeat Tau and is involved in neurodegeneration of tauopathy. J. Neurochem. 91, 299-307.
38. Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
39. Heck, J. W., Cheung, S. K. and Hampton, R. Y. (2010). Cytoplasmic protein quality control degradation mediated by parallel actions of the E3 ubiquitin ligases Ubr1 and San1. Proc. Natl. Acad. Sci. USA 107, 1106-1111.
40. Hibbert, R. G., Huang, A., Boelens, R. and Sixma, T. K. (2011). E3 ligase Rad18 promotes monoubiquitination rather than ubiquitin chain formation by E2 enzyme Rad6. Proc. Natl. Acad. Sci. USA 108, 5590-5595.
41. Hohfeld, J., Cyr, D. M. and Patterson, C. (2001). From the cradle to the grave: molecular chaperones that may choose between folding and degradation. EMBO Rep. 2, 885-890.
42. Honda, R. and Yasuda, H. (2000). Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19, 1473-1476.
43. Honda, R., Tanaka, H. and Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27.
44. Hu, S. and Yang, X. (2003). Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J. Biol. Chem. 278, 10055-10060.
45. Hua, Z. and Vierstra, R. D. (2011). The cullin-RING ubiquitin-protein ligases. Annu. Rev. Plant Biol. 62, 299-334.
46. Huang, L., Kinnucan, E., Wang, G., Beaudenon, S., Howley, P. M., Huibregtse, J. M. and Pavletich, N. P. (1999). Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286, 1321-1326.
47. Huang, L. E., Gu, J., Schau, M. and Bunn, H. F. (1998). Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitinproteasome pathway. Proc. Natl. Acad. Sci. USA 95, 7987-7992.
48. Huibregtse, J. M., Scheffner, M., Beaudenon, S. and Howley, P. M. (1995). A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92, 2563-2567.
49. Ishikura, S., Weissman, A. M. and Bonifacino, J. S. (2010). Serine residues in the cytosolic tail of the T-cell antigen receptor alpha-chain mediate ubiquitination and endoplasmic reticulum-associated degradation of the unassembled protein. J. Biol. Chem. 285, 23916-23924.
50. Iwai, K., Yamanaka, K., Kamura, T., Minato, N., Conaway, R. C., Conaway, J. W., Klausner, R. D. and Pause, A. (1999). Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA 96, 12436-12441.
51. Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A., Hebestreit, H. F., Mukherji, M., Schofield, C. J. et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472.
52. Jana, N. R., Dikshit, P., Goswami, A., Kotliarova, S., Murata, S., Tanaka, K. and Nukina, N. (2005). Cochaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J. Biol. Chem. 280, 11635-11640.
53. Kaelin, W. G., Jr and Ratcliffe, P. J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393-402.
54. Kamadurai, H. B., Souphron, J., Scott, D. C., Duda, D. M., Miller, D. J., Stringer, D., Piper, R. C. and Schulman, B. A. (2009). Insights into ubiquitin transfer cascades from a structure of a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex. Mol. Cell 36, 1095-1102.
55. Kamura, T., Koepp, D. M., Conrad, M. N., Skowyra, D., Moreland, R. J., Iliopoulos, O., Lane, W. S., Kaelin, W. G., Jr, Elledge, S. J., Conaway, R. C. et al. (1999). Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284, 657-661.
56. Kibel, A., Iliopoulos, O., DeCaprio, J. A. and Kaelin, W. G., Jr (1995). Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 269, 1444-1446.
57. Kikkert, M., Doolman, R., Dai, M., Avner, R., Hassink, G., van Voorden, S., Thanedar, S., Roitelman, J., Chau, V. and Wiertz, E. (2004). Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J. Biol. Chem. 279, 3525-3534.
58. Kim, H. C. and Huibregtse, J. M. (2009). Polyubiquitination by HECT E3s and the determinants of chain type specificity. Mol. Cell. Biol. 29, 3307-3318.
59. Kirkin, V. and Dikic, I. (2011). Ubiquitin networks in cancer. Curr. Opin. Genet. Dev. 21, 21-28.
60. Kleiger, G., Saha, A., Lewis, S., Kuhlman, B. and Deshaies, R. J. (2009). Rapid E2-E3 assembly and disassembly enable processive ubiquitylation of cullin-RING ubiquitin ligase substrates. Cell 139, 957-968.
61. Komander, D. (2009). The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 37, 937-953.
62. Kubbutat, M. H., Jones, S. N. and Vousden, K. H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
63. Kundrat, L. and Regan, L. (2010). Balance between folding and degradation for Hsp90-dependent client proteins: a key role for CHIP. Biochemistry 49, 7428-7438.
64. Lee, J. N., Song, B., DeBose-Boyd, R. A. and Ye, J. (2006). Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J. Biol. Chem. 281, 39308-39315.
65. Lee, J. T. and Gu, W. (2010). The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 17, 86-92.
66. Levin, I., Eakin, C., Blanc, M. P., Klevit, R. E., Miller, S. I. and Brzovic, P. S. (2010). Identification of an unconventional E3 binding surface on the UbcH5 ~ Ub conjugate recognized by a pathogenic bacterial E3 ligase. Proc. Natl. Acad. Sci. USA 107, 2848-2853.
67. Li, W., Tu, D., Brunger, A. T. and Ye, Y. (2007). A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate. Nature 446, 333-337.
68. Li, W., Bengtson, M. H., Ulbrich, A., Matsuda, A., Reddy, V. A., Orth, A., Chanda, S. K., Batalov, S. and Joazeiro, C. A. (2008). Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS ONE 3, e1487.
69. Li, W., Tu, D., Li, L., Wollert, T., Ghirlando, R., Brunger, A. T. and Ye, Y. (2009). Mechanistic insights into active site-associated polyubiquitination by the ubiquitinconjugating enzyme Ube2g2. Proc. Natl. Acad. Sci. USA 106, 3722-3727.
70. Liew, C. W., Sun, H., Hunter, T. and Day, C. L. (2010). RING domain dimerization is essential for RNF4 function. Biochem. J. 431, 23-29.
71. Linke, K., Mace, P. D., Smith, C. A., Vaux, D. L., Silke, J. and Day, C. L. (2008). Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ. 15, 841-848.
72. Lipkowitz, S. and Weissman, A. M. (2011). RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 11, 629-643.
73. Lisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M. and Krek, W. (1999). The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitinprotein ligase activity. Genes Dev. 13, 1822-1833.
74. Lonergan, K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R. C., Conaway, J. W. and Kaelin, W. G., Jr (1998). Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol. Cell. Biol. 18, 732-741.
75. Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S. and Weissman, A. M. (1999). RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96, 11364-11369.
76. Mace, P. D., Linke, K., Feltham, R., Schumacher, F. R., Smith, C. A., Vaux, D. L., Silke, J. and Day, C. L. (2008). Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitinconjugating enzyme (E2) recruitment. J. Biol. Chem. 283, 31633-31640.
77. MacFarlane, M., Merrison, W., Bratton, S. B. and Cohen, G. M. (2002). Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J. Biol. Chem. 277, 36611-36616.
78. Magnifico, A., Ettenberg, S., Yang, C., Mariano, J., Tiwari, S., Fang, S., Lipkowitz, S. and Weissman, A. M. (2003). WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J. Biol. Chem. 278, 43169-43177.
79. Majmundar, A. J., Wong, W. J. and Simon, M. C. (2010). Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40, 294-309.
80. Marmor, M. D. and Yarden, Y. (2004). Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene 23, 2057-2070.
81. Mattera, R., Tsai, Y. C., Weissman, A. M. and Bonifacino, J. S. (2006). The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. J. Biol. Chem. 281, 6874-6883.
82. Metzger, M. B., Maurer, M. J., Dancy, B. M. and Michaelis, S. (2008). Degradation of a cytosolic protein requires endoplasmic reticulum-associated degradation machinery. J. Biol. Chem. 283, 32302-32316.
83. Morito, D., Hirao, K., Oda, Y., Hosokawa, N., Tokunaga, F., Cyr, D. M., Tanaka, K., Iwai, K. and Nagata, K. (2008). Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508. Mol. Biol. Cell 19, 1328-1336.
84. Morizane, Y., Honda, R., Fukami, K. and Yasuda, H. (2005). X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. J. Biochem. 137, 125-132.
85. Nakayama, K., Frew, I. J., Hagensen, M., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument-Bromage, H., Tempst, P., Frappell, P. B. et al. (2004). Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell 117, 941-952.
86. Nakayama, K. I. and Nakayama, K. (2006). Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6, 369-381.
87. Nikolay, R., Wiederkehr, T., Rist, W., Kramer, G., Mayer, M. P. and Bukau, B. (2004). Dimerization of the human E3 ligase CHIP via a coiled-coil domain is essential for its activity. J. Biol. Chem. 279, 2673-2678.
88. Nillegoda, N. B., Theodoraki, M. A., Mandal, A. K., Mayo, K. J., Ren, H. Y., Sultana, R., Wu, K., Johnson, J., Cyr, D. M. and Caplan, A. J. (2010). Ubr1 and Ubr2 function in a quality control pathway for degradation of unfolded cytosolic proteins. Mol. Biol. Cell 21, 2102-2116.
89. Ogunjimi, A. A., Briant, D. J., Pece-Barbara, N., Le Roy, C., Di Guglielmo, G. M., Kavsak, P., Rasmussen, R. K., Seet, B. T., Sicheri, F. and Wrana, J. L. (2005). Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol. Cell 19, 297-308.
90. Ohh, M. (2006). Ubiquitin pathway in VHL cancer syndrome. Neoplasia 8, 623-629.
91. Omura, T., Kaneko, M., Okuma, Y., Orba, Y., Nagashima, K., Takahashi, R., Fujitani, N., Matsumura, S., Hata, A., Kubota, K. et al. (2006). A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin. J. Neurochem. 99, 1456-1469.
92. Ozkan, E., Yu, H. and Deisenhofer, J. (2005). Mechanistic insight into the allosteric activation of a ubiquitinconjugating enzyme by RING-type ubiquitin ligases. Proc. Natl. Acad. Sci. USA 102, 18890-18895.
93. Pabarcus, M. K., Hoe, N., Sadeghi, S., Patterson, C., Wiertz, E. and Correia, M. A. (2009). CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch. Biochem. Biophys. 483, 66-74.
94. Park, Y. C., Burkitt, V., Villa, A. R., Tong, L. and Wu, H. (1999). Structural basis for self-association and receptor recognition of human TRAF2. Nature 398, 533-538.
95. Pause, A., Lee, S., Worrell, R. A., Chen, D. Y., Burgess, W. H., Linehan, W. M. and Klausner, R. D. (1997). The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl. Acad. Sci. USA 94, 2156-2161.
96. Peschard, P., Fournier, T. M., Lamorte, L., Naujokas, M. A., Band, H., Langdon, W. Y. and Park, M. (2001). Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell 8, 995-1004.
97. Peters, J. M. (2006). The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat. Rev. Mol. Cell Biol. 7, 644-656.
98. Petroski, M. D. and Deshaies, R. J. (2005). Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6, 9-20.
99. Petrucelli, L., Dickson, D., Kehoe, K., Taylor, J., Snyder, H., Grover, A., De Lucia, M., McGowan, E., Lewis, J., Prihar, G. et al. (2004). CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703-714.
100. Polekhina, G., House, C. M., Traficante, N., Mackay, J. P., Relaix, F., Sassoon, D. A., Parker, M. W. and Bowtell, D. D. (2002). Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling. Nat. Struct. Biol. 9, 68-75.
101. Pringa, E., Martinez-Noel, G., Muller, U. and Harbers, K. (2001). Interaction of the ring finger-related U-box motif of a nuclear dot protein with ubiquitin-conjugating enzymes. J. Biol. Chem. 276, 19617-19623.
102. Quezada, C. M., Hicks, S. W., Galan, J. E. and Stebbins, C. E. (2009). A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases. Proc. Natl. Acad. Sci. USA 106, 4864-4869.
103. Ravid, T. and Hochstrasser, M. (2007). Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue. Nat. Cell Biol. 9, 422-427.
104. Rotin, D. and Kumar, S. (2009). Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 10, 398-409.
105. Rotin, D. and Staub, O. (2011). Role of the ubiquitin system in regulating ion transport. Pflugers Arch. 461, 1-21.
106. Satijn, D. P. and Otte, A. P. (1999). RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity. Mol. Cell. Biol. 19, 57-68.
107. Schile, A. J., Garcia-Fernandez, M. and Steller, H. (2008). Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 22, 2256-2266.
108. Sharp, D. A., Kratowicz, S. A., Sank, M. J. and George, D. L. (1999). Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J. Biol. Chem. 274, 38189-38196.
109. Shenoy, S. K., Xiao, K., Venkataramanan, V., Snyder, P. M., Freedman, N. J. and Weissman, A. M. (2008). Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J. Biol. Chem. 283, 22166-22176.
110. Shimizu, Y., Okuda-Shimizu, Y. and Hendershot, L. M. (2010). Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids. Mol. Cell 40, 917-926.
111. Shimura, H., Schwartz, D., Gygi, S. P. and Kosik, K. S. (2004). CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279, 4869-4876.
112. Shmueli, A., Tsai, Y. C., Yang, M., Braun, M. A. and Weissman, A. M. (2009). Targeting of gp78 for ubiquitinmediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum. Biochem. Biophys. Res. Commun. 390, 758-762.
113. Silke, J., Kratina, T., Chu, D., Ekert, P. G., Day, C. L., Pakusch, M., Huang, D. C. and Vaux, D. L. (2005). Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc. Natl. Acad. Sci. USA 102, 16182-16187.
114. Simons, A. M., Horwitz, A. A., Starita, L. M., Griffin, K., Williams, R. S., Glover, J. N. and Parvin, J. D. (2006). BRCA1 DNA-binding activity is stimulated by BARD1. Cancer Res. 66, 2012-2018.
115. Stagg, H. R., Thomas, M., van den Boomen, D., Wiertz, E. J., Drabkin, H. A., Gemmill, R. M. and Lehner, P. J. (2009). The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER. J. Cell Biol. 186, 685-692.
116. Staub, O., Abriel, H., Plant, P., Ishikawa, T., Kanelis, V., Saleki, R., Horisberger, J. D., Schild, L. and Rotin, D. (2000). Regulation of the epithelial Na+ channel by Nedd4 and ubiquitination. Kidney Int. 57, 809-815.
117. Suzuki, Y., Nakabayashi, Y. and Takahashi, R. (2001). Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fasinduced cell death. Proc. Natl. Acad. Sci. USA 98, 8662-8667.
118. Swaminathan, G. and Tsygankov, A. Y. (2006). The Cbl family proteins: ring leaders in regulation of cell signaling. J. Cell Physiol. 209, 21-43.
119. Swanson, R., Locher, M. and Hochstrasser, M. (2001). A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ERassociated and Matalpha2 repressor degradation. Genes Dev. 15, 2660-2674.
120. Tait, S. W., de Vries, E., Maas, C., Keller, A. M., D'Santos, C. S. and Borst, J. (2007). Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. J. Cell Biol. 179, 1453-1466.
121. Tcherpakov, M., Delaunay, A., Toth, J., Kadoya, T., Petroski, M. D. and Ronai, Z. A. (2009). Regulation of endoplasmic reticulum-associated degradation by RNF5-dependent ubiquitination of JNK-associated membrane protein (JAMP). J. Biol. Chem. 284, 12099-12109.
122. Tetzlaff, J. E., Putcha, P., Outeiro, T. F., Ivanov, A., Berezovska, O., Hyman, B. T. and McLean, P. J. (2008). CHIP targets toxic alpha-Synuclein oligomers for degradation. J. Biol. Chem. 283, 17962-17968.
123. Tsai, Y. C., Mendoza, A., Mariano, J. M., Zhou, M., Kostova, Z., Chen, B., Veenstra, T., Hewitt, S. M., Helman, L. J., Khanna, C. et al. (2007). The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat. Med. 13, 1504-1509.
124. Verdecia, M. A., Joazeiro, C. A., Wells, N. J., Ferrer, J. L., Bowman, M. E., Hunter, T. and Noel, J. P. (2003). Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase. Mol. Cell 11, 249-259.
125. Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J. and Vaux, D. L. (2000). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43-53.
126. Vierstra, R. D. (2009). The ubiquitin-26S proteasome system at the nexus of plant biology. Nat. Rev. Mol. Cell Biol. 10, 385-397.
127. Vijay-Kumar, S., Bugg, C. E. and Cook, W. J. (1987). Structure of ubiquitin refined at 1.8 A resolution. J. Mol. Biol. 194, 531-544.
128. Vucic, D., Dixit, V. M. and Wertz, I. E. (2011). Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat. Rev. Mol. Cell Biol. 12, 439-452.
129. Wade, M., Wang, Y. V. and Wahl, G. M. (2010). The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 20, 299-309.
130. Wang, M. and Pickart, C. M. (2005). Different HECT domain ubiquitin ligases employ distinct mechanisms of polyubiquitin chain synthesis. EMBO J. 24, 4324-4333.
131. Wang, X., Herr, R. A., Chua, W. J., Lybarger, L., Wiertz, E. J. and Hansen, T. H. (2007). Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 177, 613-624.
132. Weissman, A., Shabek, N. and Ciechanover, A. (2011). The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat. Rev. Mol. Cell Biol. 12, 605-620.
133. Wenzel, D. M., Lissounov, A., Brzovic, P. S. and Klevit, R. E. (2011). UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 474, 105-108.
134. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L. et al. (2004). De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694-699.
135. Williams, C., van den Berg, M., Sprenger, R. R. and Distel, B. (2007). A conserved cysteine is essential for Pex4p-dependent ubiquitination of the peroxisomal import receptor Pex5p. J. Biol. Chem. 282, 22534-22543.
136. Williams, R. L. and Urbe, S. (2007). The emerging shape of the ESCRT machinery. Nat. Rev. Mol. Cell Biol. 8, 355-368.
137. Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M. C., Hwang, L. Y., Bowcock, A. M. and Baer, R. (1996). Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14, 430-440.
138. Yamasaki, S., Yagishita, N., Sasaki, T., Nakazawa, M., Kato, Y., Yamadera, T., Bae, E., Toriyama, S., Ikeda, R., Zhang, L. et al. (2007). Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J. 26, 113-122.
139. Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M. and Ashwell, J. D. (2000). Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874-877.
140. Younger, J. M., Chen, L., Ren, H. Y., Rosser, M. F., Turnbull, E. L., Fan, C. Y., Patterson, C. and Cyr, D. M. (2006). Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126, 571-582.
141. Yu, F., White, S. B., Zhao, Q. and Lee, F. S. (2001). HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98, 9630-9635.
142. Zavacki, A. M., Arrojo, E. D. R., Freitas, B. C., Chung, M., Harney, J. W., Egri, P., Wittmann, G., Fekete, C., Gereben, B. and Bianco, A. C. (2009). The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase. Mol. Cell. Biol. 29, 5339-5347.
143. Zhang, M., Windheim, M., Roe, S. M., Peggie, M., Cohen, P., Prodromou, C. and Pearl, L. H. (2005). Chaperoned ubiquitylation-crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex. Mol. Cell 20, 525-538.
144. Zheng, N., Wang, P., Jeffrey, P. D. and Pavletich, N. P. (2000). Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533-539.
145. Zhong, X., Shen, Y., Ballar, P., Apostolou, A., Agami, R. and Fang, S. (2004). AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J. Biol. Chem. 279, 45676-45684.